Article
Targeting RNA G-quadruplex with repurposed drugs blocks SARS-CoV-2 entry
26 Jan 2023
Abstract excerpt
The rapid emergence of SARS-CoV-2 variants of concern, the complexity of infection, and the functional redundancy of host factors, underscore an urgent need for broad-spectrum antivirals against the continuous COVID-19 pandemic, with drug repurposing as a viable therapeutic strategy. Here we report the potential of RNA G-quadruplex (RG4)-targeting therapeutic strategy for SARS-CoV-2 entry. Combining...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
